REPROGRAM | REPAIR | REDEFINE
Aging can be redefined. We’re leading the way.
Life Biosciences is developing innovative therapies to transform how we treat diseases by targeting aging biology.
REPROGRAM | REPAIR | REDEFINE
Aging can be redefined. We’re leading the way.
Life Biosciences is developing innovative therapies to transform how we treat diseases by targeting aging biology.
Targeting the biology of aging
Aging is the biggest risk factor for most chronic disease. Groundbreaking research has demonstrated that aging is modifiable and caused by a discrete number of biological mechanisms that can be targeted therapeutically. We’re developing innovative therapeutics targeting the biology of aging as a new way to treat aging-related diseases.
Two Core Platforms
Our platforms are based on science from world-leading researchers. They each have the potential to prevent, treat, and/or reverse age-related diseases that currently have little to no therapeutic options.
News
- May 23, 2023
Life Biosciences Expands Team with the Appointment of Ming Yang, Ph.D., as SVP of Research and Development - May 8, 2023
Life Biosciences and Forge Biologics Announce cGMP Manufacturing Partnership to Advance Development of Novel Gene Therapies for Aging- Related Diseases - April 23, 2023
Life Biosciences Presents Groundbreaking Data at ARVO Demonstrating Restoration of Visual Function in Nonhuman Primates - February 13, 2023
Life Biosciences Appoints Sharon Rosenzweig-Lipson, PhD as Chief Scientific Officer - February 9, 2023
Life Biosciences CEO Jerry McLaughlin to Speak at Roadmap to Healthy Longevity International Summit
